Insider · CIK 0001209330

KILEY THOMAS

Reports to the SEC for 4 companies · POINT RICHMOND, CA

sec.gov

Transactions

Companies

Filings

CIK

0001209330

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2015-03-12	Ceres, Inc.Stock Option (Right To Buy)A Award	Director	AAward	+5,833 sh	—	—	5,833
2014-10-30	Paratek Pharmaceuticals, Inc.Stock option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−833 sh	—	—	0
2014-10-30	Paratek Pharmaceuticals, Inc.Stock option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−333 sh	—	—	0
2014-10-30	Paratek Pharmaceuticals, Inc.Stock option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−158 sh	—	—	0
2014-10-30	Paratek Pharmaceuticals, Inc.Stock option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−583 sh	—	—	0
2014-10-30	Paratek Pharmaceuticals, Inc.Stock option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−583 sh	—	—	0
2014-10-30	Paratek Pharmaceuticals, Inc.Stock option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−1,125 sh	—	—	0
2014-03-07	Ceres, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+5,833 sh	—	—	5,833
2013-05-22	GERNGERON CORPD Disposition to Issuer	Director	DDisposition to Issuer	−53.2K sh	—	—	171,911
2013-03-21	Ceres, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+5,833 sh	—	—	5,833
2013-01-07	Paratek Pharmaceuticals, Inc.Common Stock Option (right to buy)A Award	Director	AAward	+13.5K sh	—	—	13,500
2012-12-31	GERNGERON CORPD Disposition to Issuer	Director	DDisposition to Issuer	−2,500 sh	—	—	225,067
2012-11-05	Ceres, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+16.7K sh	$1.95	+$32.5K	16,666
2012-11-05	Ceres, Inc.Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−16.7K sh	—	—	0
2012-05-17	GERNGERON CORP · Stock Option (right to buy)A Award	Director	AAward	+35K sh	—	—	35,000
2012-05-03	Ceres, Inc.Stock Option (Right To Buy)A Award	Director	AAward	+5,833 sh	—	—	5,833
2012-02-27	Ceres, Inc.C Conversion	Director	CConversion	+5,128 sh	—	—	5,128
2012-02-27	Ceres, Inc.C Conversion	Director	CConversion	+9,615 sh	—	—	14,743
2012-02-27	Ceres, Inc.Series G Convertible Preferred StockC Conversion	Director	CConversion	−15.4K sh	—	—	0
2012-02-27	Ceres, Inc.Convertible Subordinated Promissory NoteC Conversion	Director	CConversion	—	—	—	0
2012-02-21	Ceres, Inc.Convertible Subordinated Promissory NoteJ Other	Director	JOther	—	—	—	—
2012-01-24	Paratek Pharmaceuticals, Inc.Common Stock (right to buy)A Award	Director	AAward	+7,000 sh	—	—	7,000
2011-12-28	Paratek Pharmaceuticals, Inc.G Gift	Director	GGift	−3,200 sh	—	—	67,169
2011-11-22	GERNGERON CORPP Purchase	Director	PPurchase	+64.3K sh	$1.56	+$100K	314,059
2011-10-05	GERNGERON CORPP Purchase	Director	PPurchase	+50K sh	$2.03	+$101K	96,653
2011-08-25	Paratek Pharmaceuticals, Inc.A Award	Director	AAward	+50K sh	$2.72	+$136K	70,369
2011-05-20	GERNGERON CORPA Award	Director	AAward	+2,500 sh	—	—	225,067
2011-05-20	GERNGERON CORPA Award	Director	AAward	+2,500 sh	—	—	227,567
2011-05-11	GERNGERON CORPA Award	Director	AAward	+4,073 sh	—	—	206,567
2011-05-11	GERNGERON CORPA Award	Director	AAward	+6,000 sh	—	—	212,567
2011-05-11	GERNGERON CORPA Award	Director	AAward	+2,500 sh	—	—	215,067
2011-05-11	GERNGERON CORPA Award	Director	AAward	+7,500 sh	—	—	222,567
2011-05-11	GERNGERON CORP · Stock Option (right to buy)A Award	Director	AAward	+12K sh	—	—	12,000
2011-01-27	Paratek Pharmaceuticals, Inc.Common Stock (right to buy)A Award	Director	AAward	+7,000 sh	—	—	7,000
2010-07-09	GERNGERON CORPA Award	Director	AAward	+9,000 sh	—	—	166,494
2010-07-09	GERNGERON CORPA Award	Director	AAward	+9,000 sh	—	—	175,494
2010-07-09	GERNGERON CORPA Award	Director	AAward	+9,000 sh	—	—	184,494
2010-07-09	GERNGERON CORPA Award	Director	AAward	+18K sh	—	—	202,494
2010-05-19	GERNGERON CORPA Award	Director	AAward	+3,781 sh	$5.29	+$20K	151,869
2010-05-19	GERNGERON CORPA Award	Director	AAward	+5,625 sh	—	—	157,494
2010-05-19	GERNGERON CORP · Stock Option (right to buy)A Award	Director	AAward	+11.3K sh	—	—	11,250
2010-05-19	GERNGERON CORP · Stock Option (right to buy)A Award	Director	AAward	+5,000 sh	—	—	5,000
2010-02-03	Paratek Pharmaceuticals, Inc.Common Stock Option (right to buy)A Award	Director	AAward	+1,900 sh	—	—	1,900
2010-01-14	Paratek Pharmaceuticals, Inc.Common Stock Option (right to buy)A Award	Director	AAward	+4,000 sh	—	—	4,000
2009-05-29	GERNGERON CORPA Award	Director	AAward	+3,067 sh	$6.52	+$20K	122,463
2009-05-29	GERNGERON CORPA Award	Director	AAward	+5,625 sh	—	—	128,088
2009-05-29	GERNGERON CORPA Award	Director	AAward	+20K sh	—	—	148,088
2009-05-29	GERNGERON CORP · Stock Option (right to buy)A Award	Director	AAward	+11.3K sh	$6.52	+$73.4K	136,250
2009-05-29	GERNGERON CORP · Stock Option (right to buy)A Award	Director	AAward	+5,000 sh	$6.52	+$32.6K	141,250
2009-01-30	Paratek Pharmaceuticals, Inc.A Award	Director	AAward	+31.7K sh	—	—	31,660

Recent filings

Accepted (ET)
Mar 164
Ceres, Inc.0001144204-15-016447
SEC(opens sec.gov)
Oct 304
Transcept Pharmaceuticals Inc0001181431-14-035088
SEC(opens sec.gov)
Mar 114
Ceres, Inc.0001209191-14-019238
SEC(opens sec.gov)
May 244
KILEY THOMAS0000886744-13-000066
SEC(opens sec.gov)
Mar 254
KILEY THOMAS0001209191-13-018221
SEC(opens sec.gov)
Jan 84
KILEY THOMAS0001181431-13-002498
SEC(opens sec.gov)
Jan 34
KILEY THOMAS0000886744-13-000010
SEC(opens sec.gov)
Nov 64
KILEY THOMAS0001209191-12-052026
SEC(opens sec.gov)
May 184
KILEY THOMAS0000886744-12-000059
SEC(opens sec.gov)
May 74
KILEY THOMAS0001181431-12-028105
SEC(opens sec.gov)
Feb 284
KILEY THOMAS0000947871-12-000188
SEC(opens sec.gov)

Companies

Address

C/O TRANSCEPT PHARMACEUTICALS, INC. 1003 W. CUTTING BLVD., SUITE #110

POINT RICHMOND, CA, 94804